Orencia (abatacept) / Simcere, Ono Pharma, BMS  >>  Phase 4
Welcome,         Profile    Billing    Logout  

23 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Orencia (abatacept) / BMS
2013-003956-18: Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis (JIA) Preventie van recidieven door risico-aangepast staken van de behandeling bij juveniele idiopathische artritis (JIA)

Ongoing
4
325
Europe
enbrel, humira, orencia, methotrexate, Methotrexate, EU/1/99/126/001, EU/1/03/256/001, EU/1/07/389/001, RVG 28636, RVG 104433, Injection, Infusion, Tablet, enbrel, humira, orencia, methotrexate
University Medical Center Utrecht, Interdisziplinäre Zentrum für Klinische Forschung Münster
juvenile idiopathic arthritis juveniele idiopathische artritis, juvenile (rheumatoid) arthritis jeugdreuma, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2008-005450-20: The cost-effectiveness of abatacept, rituximab or anti-TNF alpha for patients with rheumatoid artritis.

Ongoing
4
33
Europe
Remicade (infliximab), Humira (adalimumab), Enbrel (etanercept), Mabthera (rituximab), Orencia (abatacept), Remicade (infliximab), Humira (adalimumab), Enbrel (etanercept), Mabthera (rituximab), Orencia (abatacept)
Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
Rheumatoid arthritis
 
 
2012-004482-40: Evaluation of a protocol for the reduction of doses in patients with rheumatoid arthritis (RA) in clinical remission in treatment with biological therapies Evaluación de un protocolo para la disminución de dosis en pacientes con Artritis Reumatoide (AR) en remisión clínica en tratamiento con terapias biológicas

Ongoing
4
28
Europe
Infliximab, Adalimumab, Etanercept, Certolizumab Pegol, Golimumab, Abatacept, Tocilizumab, HUMIRA, ENBREL, CIMZIA, SIMPONI, ORENCIA, RoActemra, HUMIRA, ENBREL, CIMZIA, SIMPONI, ORENCIA, RoActemra
FRANCISCO J. BLANCO GARCÍA, FRANCISCO J. BLANCO GARCIA
Evaluation of the clinical utility of a standardized protocol of strategies for the reduction of doses in patients with rheumatoid arthritis in clinical remission at treatment with biologic therapies Evaluación de la utilidad clínica de un protocolo estandarizado de estrategias para la disminución de dosis en pacientes con Artritis Reumatoide en remisión clínica a tratamiento con terapias biológicas
 
 
2015-000833-64: Comparaison de trois biomédicaments en termes d’évolution des sous-populations lymphocytaires régulatrices et pro-inflammatoires chez des patients atteints de polyarthrite rhumatoïde.

Not yet recruiting
4
110
Europe
Powder for concentrate for solution for injection/infusion, Solution for infusion, ORENCIA, MABTHERA, ROACTEMRA
CHU Amiens-Picardie
Rheumatoid arthritis polyarthrite rhumatoïde, Rheumatoid arthritis Polyarthrite rhumatoïde, Diseases [C] - Immune System Diseases [C20]
 
 
2017-001970-41: Dose reduction and withdrawal of biological therapy in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: Protocol for a 18 months multi-centre trial

Ongoing
4
180
Europe
Abatacept, Adalimumab, Certolizumab pegol, Etanercept, Golimumab, Infliximab, Tocilizumab, L04AA24, L04AB04, L04AB05, L04AB01, L04AB06, L04AB02, L04AC07, Concentrate for solution for injection, Concentrate and solvent for solution for infusion, Concentrate and solvent for solution for injection, Concentrate and solvent for suspension for injection, Orencia, Humira, Cimzia, Enbrel, Benepali, Simponi, Remsima, Remicade, RoActemra, Inflectra, Imraldi, Amgevita
MD, PhD Salome Kristensen, The Danish Regions (Regionernes Medicinpulje), The Department of Rheumatology at Aalborg University Hospital, Health Science Research Fund of the Region of Northern Jutland
Rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, Rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis (arthritis of the spine), Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2017-002878-38: Abatacept to Silence anti-Citrullinated protein Antibody-expressing B cells in Rheumatoid Arthritis

Ongoing
4
46
Europe
Solution for infusion in pre-filled syringe, Orencia 125 mg
Leiden University Medical Center, BMS, IMI
Patients with early, methotrexate-naïve, ACPA-positive rheumatoid arthritis, Patients with early, methotrexate-naïve, ACPA-positive rheumatoid arthritis, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2017-004543-20: EFFECTS OF ABATACEPT ON THE PROGRESSION TO RHEUMATOID ARTHRITIS IN PATIENTS WITH PALINDROMIC RHEUMATISM (PALABA). EFECTOS DE ABATACEPT EN LA PROGRESIÓN DE LA ARTRITIS REUMATOIDE EN PACIENTES CON REUMATISMO PALINDRÓMICO (PALABA).

Not yet recruiting
4
98
Europe
Powder and solution for solution for injection, Coated tablet, ORENCIA, Dolquine
Fundació Clínic per a la Recerca Biomèdica, Bristol_ Myers Squibb . (BMS_Laboratorio)
PALINDROMIC RHEUMATISM REUMATISMO PALINDROMICO, Palindromic rheumatism is characterized by multiple recurrent episodes of arthritis and periarthritis (mono or oligoarticular) that may last hours or days, disappearing without sequels El reumatismo palindrómico se caracteriza por múltiples episodios recurrentes de artritis y periartritis (mono u oligoarticular) que pueden durar horas o días, desapareciendo sin secuelas., Diseases [C] - Immune System Diseases [C20]
 
 
NCT03700021: Response to Treatment With Intravenous Abatacept Adults With Rheumatoid Arthritis

Not yet recruiting
4
25
US
Abatacept + csDMARD
New York University School of Medicine
Rheumatoid Arthritis
11/19
11/19
2019-001754-25: Using adalimumab serum concentration to choose a subsequent biological treatment in rheumatoid arthritis patients failing adalimumab treatment

Not yet recruiting
4
84
Europe
Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab, Injection, Enbrel, Benepali, Erelzi Rituximab: mabthera, Rixathon, Truxima Abatacept: Orencia Tocilizumab: Roactemra Sarilumab: Kevzara
Reade, ZonMw
rheumatoid arthritis, Rheumatoid arthritis, Diseases [C] - Immune System Diseases [C20]
 
 
2019-004468-23: Biologics for RA Pain ( BIORA-PAIN)

Ongoing
4
60
Europe
Abatacept, Humira, Injection, Abatacept, Humira
St George's, University of London
Rheumatoid arthritis, Rheumatoid disease, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
AMiRA, NCT03619876: Effects of Abatacept on Myocarditis in Rheumatoid Arthritis

Terminated
4
11
US
Abatacept, Orencia, Adalimumab, Humira
Columbia University, Bristol-Myers Squibb
Rheumatoid Arthritis, Myocardial Inflammation
09/21
09/21
RAMBA, NCT03652961: Rheumatoid Arthritis Memory B Cells and Abatacept

Completed
4
25
US
Abatacept, DMARDs
NYU Langone Health, Dartmouth-Hitchcock Medical Center, Bristol-Myers Squibb
Rheumatoid Arthritis
09/21
09/21
NCT03882008: A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis

Completed
4
25
US
Abatacept, Orencia
University of Washington, Bristol-Myers Squibb
Rheumatoid Arthritis
06/23
06/23
ADDORA-switch, NCT04251741: Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment

Active, not recruiting
4
86
Europe
Adalimumab trough concentration, Usual care
Reade Rheumatology Research Institute, ZonMw: The Netherlands Organisation for Health Research and Development, Sint Maartenskliniek
Rheumatoid Arthritis
05/24
05/24
PALABA, NCT03669367: EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis( Study)

Active, not recruiting
4
70
Europe
Abatacept Injection, ORENCIA, hydroxycloroquina
Fundacion Clinic per a la Recerca Biomédica
Palindromic Rheumatism, Wrist
06/22
09/24
NCT05303272: A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)

Recruiting
4
60
RoW
Abatacept Prefilled Syringe, Orencia, Mycophenolate Mofetil 500Mg Tab, MMF,CellCept
Tongji Hospital, Wuhan Central Hospital, Wuhan Hospital of Traditional Chinese Medicine
Pemphigus Vulgaris
09/22
09/22
BIORA-PAIN, NCT04255134: Biologics for Rheumatoid Arthritis Pain

Completed
4
18
Europe
Abatacept Injection, Orencia, Adalimumab Injection, Humira
St George's, University of London
Rheumatoid Arthritis
10/22
10/22
NORD-STAR, NCT01491815 / 2011-004720-35: Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction

Active, not recruiting
4
812
Europe, RoW
Non-biological DMARD's, Cimzia, Orencia, RoActemra
Karolinska Institutet
Rheumatoid Arthritis
07/23
12/23
NCT02466581 / 2014-002374-36: Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity

Active, not recruiting
4
25
Europe
Sulphasalazine + Hydroxychloroquine OR Prednisolone, SSZ+HCQ or Prednisolone, Cimzia, Certolizumab-pegol, Orencia, Abatacept, RoActemra, Tocilizumab
Karolinska Institutet
Rheumatoid Arthritis
07/23
12/23
NCT05822583: Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial

Recruiting
4
1500
Europe, US, RoW
abatacept infusion, Placebo group
University of Minnesota
COVID-19
07/25
07/25
ChiCTR2100053713: The efficacy and safety of Abatacept in the treatment of antinuclear antibody (ANA) positive rheumatoid arthtits patients

Recruiting
4
60
 
Abatacept 125mg SC each week
The First Affiliated Hospital of Wenzhou Medical University; The First Affiliated Hospital of Wenzhou Medical University, None
rheumatoid arthritis
 
 
COVER, NCT05080218: COVID-19 VaccinE Response in Rheumatology Patients

Recruiting
4
1000
US
Upadacitinib, Rinvoq, Abatacept, Orencia SQ, Secukinumab, Cosentyx, Tofacitinib, Xeljanz, TNF Inhibitor, Etanercept, Certolizumab, Golimumab SQ, Adalimumab, Canakinumab Injection, Ilaris, Baricitinib, Olumiant, Ixekizumab, Taltz
Jeffrey Curtis, University of Alabama at Birmingham, University of Nebraska, University of Pennsylvania, AbbVie, Bristol-Myers Squibb, Novartis, Eli Lilly and Company, Pfizer, Illumination Health
Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis
02/24
09/24
SUNSTAR, NCT03227419 / 2017-000947-41: Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders

Recruiting
4
224
Europe
Tocilizumab Prefilled Syringe, RoActemra, Abatacept Prefilled Syringe, Orencia
Lille Catholic University
Arthritis, Rheumatoid
09/24
11/24

Download Options